This site is intended for health professionals only
Thursday 15 November 2018
Share |

Glasgow children first in Europe to benefit from technology enabling fewer invasive cardiac procedures

Related articles

Defibrillation for sudden cardiac death comes down to the programming, researchers have found
AAC Board recognises evolocumab as a high-potential medicine with full evidence base to support widespread adoption within the NHS

Ads by Google